Navigation Links
ReSearch Pharmaceutical Services, Inc. to Present at Jefferies 2010 Global Healthcare Conference
Date:1/23/2010

FORT WASHINGTON, Pa., Jan. 22 /PRNewswire-FirstCall/ -- ReSearch Pharmaceutical Services, Inc. (RPS) today announced that Daniel Perlman, Chief Executive Officer and Steven Bell, Chief Financial Officer, will present at the Jefferies 2010 Global Healthcare Conference, which will be held January 25–27, 2010 in New York City.  

The presentation is scheduled for Wednesday, January 27, 2010, at 11:45 am, EST.  Mr. Perlman will also participate in a CRO Panel Discussion – Trends in Clinical Research at 12:25 pm, EST.

About ReSearch Pharmaceutical Services, Inc. (RPS)

Headquartered in Fort Washington, Pennsylvania, with subsidiary offices across Latin America, Europe and Asia, RPS is a next generation CRO and a leading provider of integrated clinical development and enhanced full-service outsourcing solutions to the bio-pharmaceutical industry.  RPS providers services in connection with the design, initiation and management of clinical trials programs that are required to obtain regulatory approval to market bio-pharmaceutical products.  Our innovative business model combines the expertise of a traditional CRO with the ability to provide flexible outsourcing solutions that are fully integrated within our clients' clinical drug development infrastructure.  This approach was designed to meet the varied needs of small, medium and large bio-pharmaceutical companies.  

SOURCE ReSearch Pharmaceutical Services, Inc.

RELATED LINKS
http://www.rpsweb.com

'/>"/>

SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers welcome new multiple sclerosis drug
2. Barrow researchers receive more than $2 million in NIH grants for nicotine studies
3. New research will examine link between childhood asthma, sleep and school performance
4. Barrow researcher reports that slow breathing reduces pain
5. Research Indicates Participants in Incentive-Based Health Promotion Programs Have Lower Healthcare Costs
6. Researchers discover method to objectively identify PTSD
7. Mouse Study May Advance Multiple Sclerosis Research
8. Researchers find a treatment for deadly brain tumor
9. Childhood Apraxia of Speech Association of North America Awards Treatment Research Grant to University of New Mexico/PROMPT Institute
10. Concussions not taken seriously enough: McMaster researcher
11. Researchers find new insights into inherited retinal disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... Va. (PRWEB) , ... September 21, 2017 , ... ... with a different approach to addiction recovery at a time when Virginia faces ... deaths resulting from drug overdose, a staggering increase of 38 percent from 2015, ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... the acquisition of Isle at Kingwood Assisted Living and Memory Care located at ... retirement community with 55 assisted living apartments, 43 memory care apartments and 23 ...
(Date:9/21/2017)... ... September 21, 2017 , ... In ... and Clark College Emeritus Professor of Education Gregory A. Smith examines student privacy ... Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the Failure of Policymaking . ...
(Date:9/20/2017)... CHARLOTTE, NC (PRWEB) , ... September 20, 2017 ... ... for Transformation and Centers of Excellence (CoE) with the latest Artificial Intelligence (AI) ... newly designed presence offers quick and easy access to essential information that offers ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... one of the Best Places to Work in the Research Triangle for 2017. ... Once nominated, a company had to meet a threshold in employee participation--a percentage ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology: